A novel mouse model of creatine transporter deficiency

F1000Research

Volumn 3, Issue , 2014, Pages

  Baroncelli, Laura ^a   Alessandrì, Maria Grazia ^b   Tola, Jonida ^a   Putignano, Elena ^a   Migliore, Martina ^a   Amendola, Elena ^c   Gross, Cornelius ^c   Leuzzi, Vincenzo ^d   Cioni, Giovanni ^b,e   Pizzorusso, Tommaso ^a,f  

^a CNR   (Italy)

^b SMILE Lab Department of Developmental Neuroscience IRCCS Stella Maris Scientific Institute   (Italy)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GUANIDINOACETIC ACID;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBRAL CREATINE TRANSPORTER DEFICIENCY; CONTROLLED STUDY; CRT GENE; EXON; GENE; GENE DELETION; HIPPOCAMPUS; LOCOMOTION; METABOLIC DISORDER; MOTOR ACTIVITY; MOUSE; NONHUMAN; PROTEIN DEPLETION; SLC6A8 GENE; SPATIAL LEARNING; SPATIAL MEMORY; WEIGHT REDUCTION; WORKING MEMORY;

EID: 84923165665     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.5369.1     Document Type: Article

References (36)

1. Acosta ML Kalloniatis M Christie DL: Creatine transporter localization in developing and adult retina: importance of creatine to retinal function. Am J Physiol Cell Physiol. 2005;289(4):C1015-1023. 15930147 10.1152/ajpcell.00137.2005
2. Alessandri MG Celati L Battini R: Gas chromatography/mass spectrometry assay for arginine: glycine-amidinotransferase deficiency. Anal Biochem. 2005;343(2):356-358. 15978539 10.1016/j.ab.2005.05.003
3. Anselm IA Alkuraya FS Salomons GS: X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 2006;29(1):214-219. 16601897 10.1007/s10545-006-0123-4 2393549
4. Baroncelli L Alessandrì MG Tola J: Dataset 1. Data for neurochemical and behavioral assessment in a mouse model of creatine deficiency. F1000Research. 2014. Data Source
5. Battini R Leuzzi V Carducci C: Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol Genet Metab. 2002;77(4):326-331. 12468279 10.1016/S1096-7192(02)00175-0
6. Begenisic T Baroncelli L Sansevero G: Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome. Neurobiol Dis. 2014;63:12-19. 24269730 10.1016/j.nbd.2013.11.010
7. Carducci C Carducci C Santagata S: In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism. BMC Neurosci. 2012;13:41. 22536786 10.1186/1471-2202-13-41 3355046
8. Cecil KM Salomons GS Ball WS Jr: Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol. 2001;49(3):401-404. 11261517 10.1002/ana.79
9. Chilosi A Leuzzi V Battini R: Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase. 2008;14(2):151-161. 18569740 10.1080/13554790802060821
10. deGrauw TJ Cecil KM Byars AW: The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem. 2003;244(1-2):45-48. 12701808 10.1023/A:1022487218904
11. deGrauw TJ Salomons GS Cecil KM: Congenital creatine transporter deficiency. Neuropediatrics. 2002;33(5):232-238. 12536364 10.1055/s-2002-36743
12. Farley FW Soriano P Steffen LS: Widespread recombinase expression using FLPeR (flipper) mice. Genesis. 2000;28(3-4):106-110. 11105051 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T
13. Fons C Arias A Sempere A: Response to creatine analogs in fibroblasts and patients with creatine transporter deficiency. Mol Genet Metab. 2010;99(3):296-299. 19955008 10.1016/j.ymgme.2009.10.186
14. Hahn KA Salomons GS Tackels-Horne D: X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet. 2002;70(5):1349-1356. 11898126 10.1086/340092 447610
15. Item CB Stockler-Ipsiroglu S Stromberger C: Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet. 2001;69(5):1127-1133. 11555793 10.1086/323765 1274356
16. Katz DM Berger-Sweeney JE Eubanks JH: Preclinical research in Rett syndrome: setting the foundation for translational success. Dis Model Mech. 2012;5(6):733-745. 23115203 10.1242/dmm.011007 3484856
17. Kleefstra T Rosenberg EH Salomons GS: Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin Genet. 2005;68(4):379-381. 16143026 10.1111/j.1399-0004.2005.00489.x
18. Kurosawa Y Degrauw TJ Lindquist DM: Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J Clin Invest. 2012;122(8):2837-2846. 22751104 10.1172/JCI59373 3408730
19. Lonetti G Angelucci A Morando L: Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry. 2010;67(7):657-665. 20172507 10.1016/j.biopsych.2009.12.022
20. Lowe MT Faull RL Christie DL: Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. J Comp Neurol. 2014. 25159005 10.1002/cne.23667
21. Lowry OH Rosebrough NJ Farr AL: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-275. 14907713
22. Mak CS Waldvogel HJ Dodd JR: Immunohistochemical localisation of the creatine transporter in the rat brain. Neuroscience. 2009;163(2):571-585. 19580854 10.1016/j.neuroscience.2009.06.065
23. Nash SR Giros B Kingsmore SF: Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Receptors Channels. 1994;2(2):165-174. 7953292
24. Russell AP Ghobrial L Wright CR: Creatine transporter (SLC6A8) knockout mice display an increased capacity for in vitro creatine biosynthesis in skeletal muscle. Front Physiol. 2014;5:314. 25206338 10.3389/fphys.2014.00314 4144344
25. Schmidt A Marescau B Boehm EA: Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet. 2004;13(9):905-921. 15028668 10.1093/hmg/ddh112
26. Schulze A Ebinger F Rating D: Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab. 2001;74(4):413-419. 11749046 10.1006/mgme.2001.3257
27. Skelton MR Schaefer TL Graham DL: Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS One. 2011;6(1):e16187. 21249153 10.1371/journal.pone.0016187 3020968
28. Stockler S Hanefeld F Frahm J: Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet. 1996;348(9030):789-790. 8813986 10.1016/S0140-6736(96)04116-5
29. Stockler S Holzbach U Hanefeld F: Creatine deficiency in the brain: a new treatable inborn error of metabolism. Pediatr Res. 1994;36(3):409-413. 7808840 10.1203/00006450-199409000-00023
30. Tachikawa M Fukaya M Terasaki T: Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci. 2004;20(1):144-160. 15245487 10.1111/j.1460-9568.2004.03478.x
31. Tang SH Silva FJ Tsark WM: A Cre/loxP-deleter transgenic line in mouse strain 129S1/SvImJ. Genesis. 2002;32(3):199-202. 11892008 10.1002/gene.10030
32. Valayannopoulos V Boddaert N Chabli A: Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis. 2012;35(1):151-157. 21660517 10.1007/s10545-011-9358-9
33. van de Kamp JM Mancini GM Salomons GS: X-linked creatine transporter deficiency: clinical aspects and pathophysiology. J Inherit Metab Dis. 2014;37(5):715-733. 24789340 10.1007/s10545-014-9713-8
34. van de Kamp JM Pouwels PJ Aarsen FK: Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J Inherit Metab Dis. 2012;35(1):141-149. 21556832 10.1007/s10545-011-9345-1 3249187
35. van de Kamp JM Betsalel OT Mercimek-Mahmutoglu S: Phenotype and genotype in 101 males with X-linked creatine transporter deficiency. J Med Genet. 2013;50(7):463-472. 23644449 10.1136/jmedgenet-2013-101658
36. Wyss M Kaddurah-Daouk R: Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107-1213. 10893433